Spire Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266K | Sell |
4,055
-510
| -11% | -$33.4K | 0.01% | 687 |
|
|
2025
Q1 | $322K | Sell |
4,565
-3
| -0.1% | -$212 | 0.01% | 696 |
|
|
2024
Q4 | $300K | Buy |
4,568
+906
| +25% | +$59.5K | 0.01% | 707 |
|
|
2024
Q3 | $259K | Buy |
3,662
+292
| +9% | +$20.6K | 0.01% | 671 |
|
|
2024
Q2 | $224K | Buy |
3,370
+1,176
| +54% | +$78K | 0.01% | 694 |
|
|
2024
Q1 | $149K | Buy |
2,194
+1,171
| +114% | +$79.5K | ﹤0.01% | 875 |
|
|
2023
Q4 | $64.6K | Buy |
1,023
+3
| +0.3% | +$189 | ﹤0.01% | 1117 |
|
|
2023
Q3 | $60.2K | Hold |
1,020
| – | – | ﹤0.01% | 1104 |
|
|
2023
Q2 | $60.9K | Sell |
1,020
-9
| -0.9% | -$538 | ﹤0.01% | 1126 |
|
|
2023
Q1 | $60.1K | Buy |
1,029
+384
| +60% | +$22.4K | ﹤0.01% | 1125 |
|
|
2022
Q4 | $40K | Hold |
645
| – | – | ﹤0.01% | 1063 |
|
|
2022
Q3 | $36K | Sell |
645
-348
| -35% | -$19.4K | ﹤0.01% | 1079 |
|
|
2022
Q2 | $63K | Sell |
993
-345
| -26% | -$21.9K | ﹤0.01% | 1199 |
|
|
2022
Q1 | $87K | Buy |
1,338
+3
| +0.2% | +$195 | ﹤0.01% | 1214 |
|
|
2021
Q4 | $89K | Buy |
1,335
+6
| +0.5% | +$400 | ﹤0.01% | 1448 |
|
|
2021
Q3 | $81K | Sell |
1,329
-9
| -0.7% | -$549 | ﹤0.01% | 1270 |
|
|
2021
Q2 | $83K | Buy |
1,338
+6
| +0.5% | +$372 | ﹤0.01% | 1261 |
|
|
2021
Q1 | $79K | Buy |
+1,332
| New | +$79K | ﹤0.01% | 1498 |
|